News | Scientists Identify 473 “On-Off” Genes That Could Transform Personalized Medicine
A major study published in Nature Communications identified 473 human genes that behave like switches: they are either fully active or fully inactive and show tissue-specific expression. The finding offers new possibilities for understanding disease mechanisms and advancing personalized medicine.
Genes switching on and off affect health
The team analyzed genomic (DNA), methylomic (DNA modification), and transcriptomic (RNA expression) data from 943 volunteers, screening the expression patterns of about 19,000 highly expressed genes across 27 human tissues.
They found 473 genes with a clear bimodal distribution—two extreme “on” and “off” states rather than gradual increases or decreases. This switch-like expression was closely associated with conditions including skin disease, metabolic disease, immune disorders, and cancer.
Hormonal regulation and DNA methylation determine which genes switch on or off
Most switch-like genes were tissue-specific and regulated by hormone levels. Of 158 such genes identified in breast tissue, for example, 157 were expressed mainly in women, showing a strong sex bias. In uterine tissue, the expression of key genes such as TP53INP2 declined with age and may be related to reduced female fertility.
About 8.5% of these genes showed similar two-state expression across all tissues, mainly because of genetic factors such as DNA variants, structural variants, or loss of function. For example, a common gene deletion keeps USP32P2 and FAM106A permanently “off,” which may affect male fertility and could worsen COVID-19.
Vaginal tissue research: hormone therapy can switch genes back on
In vaginal tissue samples, researchers found 7 switch-like genes associated with postmenopausal vaginal atrophy caused by estrogen deficiency. Further experiments showed that estrogen therapy could reactivate 5 of them. This supports the close relationship between their expression and hormones and suggests that hormone therapy may work partly by regulating these genes.
In vaginal tissue, ALOX12 was considered a “passenger gene”—an effect of disease—while KRT1 may be a “driver gene” that causes disease, offering potential targets for future interventions.
Closer study of switch genes could change disease diagnosis and treatment
Researchers have long focused on genes with continuous expression or gradual changes, overlooking binary patterns like a light switch. By using RNA sequencing data and statistical models, this study systematically identified these switch-like genes for the first time and addressed an important research gap.
They recommended two priorities for future research:
Use long-read sequencing to find hidden structural variants. The genetic mechanism behind the “off” state of some genes, such as GPX1P1, remains unclear;
Include switch genes in gene-environment interaction research. For example, deletion of the GSTMI gene combined with maternal smoking may significantly increase a child’s asthma risk.
Outlook: another step toward precision medicine
This study is the largest and most comprehensive integrated analysis of its kind to date. By combining genomic, methylomic, and transcriptomic data, scientists created a map of human switch genes.
Although the study noted that RNA-level “on-off” states do not always reflect protein-level changes, the finding still provides a strong foundation for early disease warnings, drug-target screening, and personalized treatment design.
If researchers can determine which genes drive disease and combine that information with individual factors such as hormones, age, and BMI, more precise disease prediction and intervention may become possible.
News | Scientists Identify 473 “On-Off” Genes That Could Transform Personalized Medicine
News | Scientists Identify 473 “On-Off” Genes That Could Transform Personalized Medicine
A major study published in Nature Communications identified 473 human genes that behave like switches: they are either fully active or fully inactive and show tissue-specific expression. The finding offers new possibilities for understanding disease mechanisms and advancing personalized medicine.
Genes switching on and off affect health
The team analyzed genomic (DNA), methylomic (DNA modification), and transcriptomic (RNA expression) data from 943 volunteers, screening the expression patterns of about 19,000 highly expressed genes across 27 human tissues.
They found 473 genes with a clear bimodal distribution—two extreme “on” and “off” states rather than gradual increases or decreases. This switch-like expression was closely associated with conditions including skin disease, metabolic disease, immune disorders, and cancer.
Hormonal regulation and DNA methylation determine which genes switch on or off
Most switch-like genes were tissue-specific and regulated by hormone levels. Of 158 such genes identified in breast tissue, for example, 157 were expressed mainly in women, showing a strong sex bias. In uterine tissue, the expression of key genes such as TP53INP2 declined with age and may be related to reduced female fertility.
About 8.5% of these genes showed similar two-state expression across all tissues, mainly because of genetic factors such as DNA variants, structural variants, or loss of function. For example, a common gene deletion keeps USP32P2 and FAM106A permanently “off,” which may affect male fertility and could worsen COVID-19.
Vaginal tissue research: hormone therapy can switch genes back on
In vaginal tissue samples, researchers found 7 switch-like genes associated with postmenopausal vaginal atrophy caused by estrogen deficiency. Further experiments showed that estrogen therapy could reactivate 5 of them. This supports the close relationship between their expression and hormones and suggests that hormone therapy may work partly by regulating these genes.
In vaginal tissue, ALOX12 was considered a “passenger gene”—an effect of disease—while KRT1 may be a “driver gene” that causes disease, offering potential targets for future interventions.
Closer study of switch genes could change disease diagnosis and treatment
Researchers have long focused on genes with continuous expression or gradual changes, overlooking binary patterns like a light switch. By using RNA sequencing data and statistical models, this study systematically identified these switch-like genes for the first time and addressed an important research gap.
They recommended two priorities for future research:
Use long-read sequencing to find hidden structural variants. The genetic mechanism behind the “off” state of some genes, such as GPX1P1, remains unclear;
Include switch genes in gene-environment interaction research. For example, deletion of the GSTMI gene combined with maternal smoking may significantly increase a child’s asthma risk.
Outlook: another step toward precision medicine
This study is the largest and most comprehensive integrated analysis of its kind to date. By combining genomic, methylomic, and transcriptomic data, scientists created a map of human switch genes.
Although the study noted that RNA-level “on-off” states do not always reflect protein-level changes, the finding still provides a strong foundation for early disease warnings, drug-target screening, and personalized treatment design.
If researchers can determine which genes drive disease and combine that information with individual factors such as hormones, age, and BMI, more precise disease prediction and intervention may become possible.
Story source:
Collected online